Abstract:Abstract The first edition of the clinical practice guidelines for liver cirrhosis was published in 2010, and the second edition was published in 2015 by the Japanese Society of Gastroenterology (JSGE). The revised third edition was recently published in 2020. This version has become a joint guideline by the JSGE and the Japan Society of Hepatology (JSH). In addition to the clinical questions (CQs), background questions (BQs) are new items for basic clinical knowledge, and future research questions (FRQs) are newly added clinically important items. Concerning the clinical treatment of liver cirrhosis, new findings have been reported over the past 5 years since the second edition. In this revision, we decided to match the international standards as much as possible by referring to the latest international guidelines. Newly developed agents for various complications have also made great progress. In comparison with the latest global guidelines, such as the European Association for the Study of the Liver (EASL) and American Association for the Study of Liver Diseases (AASLD), we are introducing data based on the evidence for clinical practice in Japan. The flowchart for nutrition therapy was reviewed to be useful for daily medical care by referring to overseas guidelines. We also explain several clinically important items that have recently received focus and were not mentioned in the last editions. This digest version describes the issues related to the management of liver cirrhosis and several complications in clinical practice. The content begins with a diagnostic algorithm, the revised flowchart for nutritional therapy, and refracted ascites, which are of great importance to patients with cirrhosis. In addition to the updated antiviral therapy for hepatitis B and C liver cirrhosis, the latest treatments for non-viral cirrhosis, such as alcoholic steatohepatitis/non-alcoholic steatohepatitis (ASH/NASH) and autoimmune-related cirrhosis, are also described. It also covers the latest evidence regarding the diagnosis and treatment of liver cirrhosis complications, namely gastrointestinal bleeding, ascites, hepatorenal syndrome and acute kidney injury, hepatic encephalopathy, portal thrombus, sarcopenia, muscle cramp, thrombocytopenia, pruritus, hepatopulmonary syndrome, portopulmonary hypertension, and vitamin D deficiency, including BQ, CQ and FRQ. Finally, this guideline covers prognosis prediction and liver transplantation, especially focusing on several new findings since the last version. Since this revision is a joint guideline by both societies, the same content is published simultaneously in the official English journal of JSGE and JSH.

Chinese Guidelines On The Management Of Liver Cirrhosis (Abbreviated Version)

Chinese consensus on the management of liver cirrhosis

Chinese Consensus on Clinical Diagnosis and Therapy of Liver Cirrhosis

Chinese guidelines on the management of ascites in cirrhosis : Chinese Society of Hepatology, Chinese Medical Association

Chinese guidelines on the management of ascites and its related complications in cirrhosis

Chinese guidelines on management of hepatic encephalopathy in cirrhosis

Guidelines of prevention and treatment for alcoholic liver disease (2018, China).

[Chinese guidelines on the management of hepatic encephalopathy in cirrhosis (2024)]

Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition).

Guidelines for the Diagnosis and Management of Alcoholic Liver Disease: Update 2010

Critical Appraisal of Chinese 2017 Guideline on the Management of Hepatocellular Carcinoma.

Critical appraisal of Chinese 2017 guideline on the management of hepatocellular carcinoma

Liver cirrhosis: current status and treatment options using western or traditional Chinese medicine

2019 Chinese clinical guidelines for the management of hepatocellular carcinoma: updates and insights

The Importance of Internal Medicine Management of Complications Associated with Liver Cirrhosis

Guidelines for diagnosis and treatment of hepatic fibrosis with integrated traditional Chinese and Western medicine (2019 edition)

Evidence-based clinical practice guidelines for Liver Cirrhosis 2020

Guidelines for the Management of Esophagogastric Variceal Bleeding in Cirrhotic Portal Hypertension.

Evidence‐based clinical practice guidelines for liver cirrhosis 2020

Clinical guidelines of non-alcoholic fatty liver disease: A systematic review.

Guidelines on the Diagnosis and Management of Primary Biliary Cholangitis (2021)